IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024
May 02, 2024 at 08:30 am EDT
IRADIMED CORPORATION provided revenue guidance for the second quarter and full year of 2024. For the second quarter of 2024, the Company expects to report revenue of $17.6 million to $17.8 million, GAAP diluted earnings per share of $0.33 to $0.36.
For the year, the company reiterates to report revenue of $72.0 million to $74.0 million, GAAP diluted earnings per share of $1.37 to $1.47.